Igc pharma announces equity analyst update by alliance global partners (agp) about the "progressing alzheimer-targeting efforts with notable phase 2 calma interim results"

Potomac, md / access newswire / march 10, 2025 / igc pharma, inc. ("igc pharma," "igc," or the "company") (nyse american:igc) announces that alliance global partners (agp) has issued an analyst update research report entitled "progressing alzheimer-targeting efforts with notable phase 2 calma interim results" all reports on igc pharma prepared by analysts represent the views of those analysts and are not necessarily those of igc pharma. igc is not responsible for the content, accuracy, or timelines provided by analysts.
IGC Ratings Summary
IGC Quant Ranking